- Min.Order :1 Kilogram
- Purity: 99%
- Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other
Keywords
Pharmaceutical Intermediates Local anesthesia, API
Quick Details
- Appearance:White or off white crystalline powder
- Application:Prilocaine HCL Cas: 1786-81-8 Standard: USP29 Appearance: White or off white crystalline powder Usage: Anesthetic(local) Package:25kg/drum,1kg/ Aluminum Foil Bag Prilocaine is a local anesthet
- PackAge:1kg/10kg/25kg/Drum
- ProductionCapacity:1|Metric Ton|Day
- Storage:STORAGE CONDITION:COOL,DRY AND ROOM TEMPERATURE
- Transportation:transportation by sea, air transportation,land carriage
Superiority:
Prilocaine HCL
Cas: 1786-81-8
Standard: USP29
Appearance: White or off white crystalline powder
Usage: Anesthetic(local)
Package:25kg/drum,1kg/ Aluminum Foil Bag
Prilocaine is a local anesthetic of the amino amide type first prepared by Claes Tegner and Nils Lö Fgren. In its injectable form, it is often used in dentistry. It is also often
combined with lidocaine as a preparation for dermal anesthesia(lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia. As it has low cardiac toxicity, it is commonly used
forintravenous regional anaesthesia.
Lidocaine Hydrochloride Topical Solution USP, 4% contains a local anesthetic agent and is administered topically. See INDICATIONS for specific uses.
Details:
Prilocaine HCL
Cas: 1786-81-8
Standard: USP29
Appearance: White or off white crystalline powder
Usage: Anesthetic(local)
Package:25kg/drum,1kg/ Aluminum Foil Bag
Prilocaine is a local anesthetic of the amino amide type first prepared by Claes Tegner and Nils Lö Fgren. In its injectable form, it is often used in dentistry. It is also often
combined with lidocaine as a preparation for dermal anesthesia(lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia. As it has low cardiac toxicity, it is commonly used
forintravenous regional anaesthesia.
Lidocaine Hydrochloride Topical Solution USP, 4% contains a local anesthetic agent and is administered topically. See INDICATIONS for specific uses.
You Might Also Like
-
raltegravir intermediate CAS:519032-08-7
CAS NO:519032-08-7
-
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol
CAS NO:1985607-83-7
-
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid
CAS NO:119736-16-2
-
Baloxavir marboxil
CAS NO:1985606-14-1
-
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
CAS NO:1985607-70-2
-
Fulvestrant intermediate
CAS NO:875573-67-4
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View